These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9206247)

  • 1. [Study on the enhancing effect of polyporus polysaccharide, mycobacterium polysaccharide and lentinan on lymphokine-activated killer cell activity in vitro].
    Li JF; Guo JW; Huang XF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Apr; 16(4):224-6. PubMed ID: 9206247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of lymphokine-activated killer cell activity by lentinan.
    Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
    Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic polysaccharide from Panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2.
    Kim KH; Lee YS; Jung IS; Park SY; Chung HY; Lee IR; Yun YS
    Planta Med; 1998 Mar; 64(2):110-5. PubMed ID: 9525101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of MPS on LAK cell growth and its cytotoxic activity against laryngeal cancer (HEP-2)].
    Wang J; Zhu X; Chen J
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(5):283-6. PubMed ID: 9642362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-12 synergizes with interleukin-2 to generate lymphokine-activated killer activity in peripheral blood mononuclear cells cultured in ovarian cancer ascitic fluid.
    Barton DP; Blanchard DK; Duan C; Roberts WS; Cavanagh D; DeCesare S; Djeu JY
    J Soc Gynecol Investig; 1995; 2(6):762-71. PubMed ID: 9420887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2.
    Suzuki M; Higuchi S; Taki Y; Taki S; Miwa K; Hamuro J
    Int J Immunopharmacol; 1990; 12(6):613-23. PubMed ID: 2272726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of human IL-2 activated cytotoxic cells.
    LeFever AV; Piaskowski VD; Casper JT; Truitt RL
    Immunopharmacol Immunotoxicol; 1991; 13(1-2):147-68. PubMed ID: 1770217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of murine lymphokine (rIL-2)-activated killer cell activity by indomethacin.
    Chao TY; Ohnishi H; Chu TM
    Mol Biother; 1989; 1(6):318-22. PubMed ID: 2610950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurine attenuates recombinant interleukin-2-activated, lymphocyte-mediated endothelial cell injury.
    Finnegan NM; Redmond HP; Bouchier-Hayes DJ
    Cancer; 1998 Jan; 82(1):186-99. PubMed ID: 9428497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LAK-cell-mediated cytotoxicity against tumor cell targets used to monitor the stimulatory effect of interleukin-2: cytotoxicity, target recognition and phenotype of effector cells lysing the Daudi, T24 and K562 tumor cell lines.
    Hermann GG; Zeuthen J; Claësson MH
    Nat Immun; 1992; 11(1):7-16. PubMed ID: 1611282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the antitumor activity of human IL-4 by in vitro and in vivo assays.
    Wang T; Chen W
    Chin Med Sci J; 1994 Dec; 9(4):248-54. PubMed ID: 7718866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro induction of lymphokine-activated killer (LAK) activity in patients with neuroblastoma.
    Handgretinger R; Bruchelt G; Kimmig A; Dopfer R; Niethammer D; Treuner J
    Pediatr Hematol Oncol; 1989; 6(4):307-17. PubMed ID: 2641703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phytochemicals potentiate interleukin-2 generated lymphokine-activated killer cell cytotoxicity against murine renal cell carcinoma.
    Wang Y; Qian XJ; Hadley HR; Lau BH
    Mol Biother; 1992 Sep; 4(3):143-6. PubMed ID: 1445669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma.
    Arinaga S; Karimine N; Takamuku K; Nanbara S; Inoue H; Nagamatsu M; Ueo H; Akiyoshi T
    Int J Immunopharmacol; 1992 May; 14(4):535-9. PubMed ID: 1521921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ; Krosnick JA; Rosenberg SA
    J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysis of herpes simplex virus-infected cells by lymphokine-activated killer cells.
    Chu CT; Lee P; Lin BJ; Sun MJ; Hsieh KH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Feb; 24(1):108-18. PubMed ID: 1657543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-4 inhibits IL-2 induction of LAK cytotoxicity in lymphocytes from a variety of lymphoid tissues.
    Colquhoun SD; Economou JS; Shau H; Golub SH
    J Surg Res; 1993 Nov; 55(5):486-92. PubMed ID: 8231167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.